We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,031 hedge funds and large institutions have $164B invested in Thermo Fisher Scientific in 2020 Q4 according to their latest regulatory filings, with 276 funds opening new positions, 751 increasing their positions, 739 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

294% more first-time investments, than exits

New positions opened: 276 | Existing positions closed: 70

10% more funds holding

Funds holding: 1,8472,031 (+184)

5% more capital invested

Capital invested by funds: $156B → $164B (+$8.53B)

2% more repeat investments, than reductions

Existing positions increased: 751 | Existing positions reduced: 739

0.99% less ownership

Funds ownership: 89.16%88.17% (-0.99%)

7% less funds holding in top 10

Funds holding in top 10: 198184 (-14)

19% less call options, than puts

Call options by funds: $976M | Put options by funds: $1.21B

Holders
2,031
Holders Change
+184
Holders Change %
+9.96%
% of All Funds
35.93%
Holding in Top 10
184
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-7.07%
% of All Funds
3.26%
New
276
Increased
751
Reduced
739
Closed
70
Calls
$976M
Puts
$1.21B
Net Calls
-$229M
Net Calls Change
-$95M
Name Holding Trade Value Shares
Change
Change in
Stake
LPT
676
Legacy Private Trust
Wisconsin
$6.62M -$820K -1,749 -11%
RJT
677
Raymond James Trust
Florida
$6.59M +$130K +278 +2%
BS
678
Banco Santander
Spain
$6.57M +$4.2M +8,963 +174%
CCC
679
Chelsea Counsel Company
California
$6.55M -$1.21M -2,573 -15%
SAM
680
Synergy Asset Management
Washington
$6.54M +$6.58M +14,043 New
AF
681
Advisornet Financial
Minnesota
$6.5M -$113K -240 -2%
ETC
682
Exchange Traded Concepts
Oklahoma
$6.49M +$5.34M +11,393 +449%
CI
683
Cigna Investments
Connecticut
$6.48M +$497K +1,061 +8%
V
684
Veritable
Delaware
$6.47M -$485K -1,035 -7%
PWS
685
Peloton Wealth Strategists
Indiana
$6.41M -$148K -315 -2%
SLI
686
Sumitomo Life Insurance
Japan
$6.37M -$899K -1,917 -12%
DWA
687
Douglass Winthrop Advisors
New York
$6.36M +$526K +1,122 +9%
AWCI
688
Alpine Woods Capital Investors
New York
$6.34M +$263K +560 +4%
PAI
689
Pittenger & Anderson Inc
Nebraska
$6.32M +$3.04M +6,473 +91%
HI
690
Harrington Investments
California
$6.31M -$336K -716 -5%
GCA
691
Greenwood Capital Associates
South Carolina
$6.25M -$97.5K -208 -2%
MCWS
692
McKinley Carter Wealth Services
West Virginia
$6.24M -$232K -494 -4%
SS
693
Simplicity Solutions
Minnesota
$6.21M +$639K +1,363 +11%
NCM
694
Nelson Capital Management
California
$6.18M -$2.46M -5,237 -28%
TNB
695
TCF National Bank
South Dakota
$6.18M +$73.1K +156 +1%
SB
696
Simmons Bank
Arkansas
$6.17M -$749K -1,597 -11%
VSWA
697
Vontobel Swiss Wealth Advisors
Switzerland
$6.17M -$143K -304 -2%
KC
698
Knuff & Co
California
$6.16M +$749K +1,597 +14%
RMCM
699
Reynders McVeigh Capital Management
Massachusetts
$6.11M -$6.56K -14 -0.1%
FFWA
700
FRG Family Wealth Advisors
Washington
$6.07M

TMO Hedge Fund Activity: Q4 2020 in Review

2,031 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2020, worth a combined $164B — up 5.5% from $156B a quarter earlier.

Buyers outnumbered sellers: 276 funds opened new TMO positions and 70 closed out — a net gain of 206 holders — while 751 added to existing stakes and 739 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $322M. The largest seller was Capital Research Global Investors, cutting an estimated $770M.

  • 2,031 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2020, up from 1,847 in Q3 2020.
  • Funds reported $164B of Thermo Fisher Scientific stock for Q4 2020, up 5.5% quarter-over-quarter.
  • 276 funds opened new Thermo Fisher Scientific positions in Q4 2020 and 70 closed out, a net change of +206 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2020 was Fidelity Investments, an estimated $322M added.
  • The largest Thermo Fisher Scientific seller in Q4 2020 was Capital Research Global Investors, an estimated $770M sold.

Based on aggregated 13F filings for Q4 2020.